BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25962143)

  • 1. Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children.
    Nguyen TV; Melville A; Nath S; Story C; Howell S; Sutton R; Zannettino A; Revesz T
    PLoS One; 2015; 10(5):e0126233. PubMed ID: 25962143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
    Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
    Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7-14 of chemotherapy.
    Kidd PG; Saminathan T; Drachtman RA; Ettinger LJ
    Med Pediatr Oncol; 1997 Dec; 29(6):541-3. PubMed ID: 9324341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow cellularity in acute lymphoblastic leukemia of children].
    Styczyński J; Kubicka M; Langer B; Wysocki M; Debski R; Wolska E; Polańska M
    Wiad Lek; 2000; 53(9-10):507-12. PubMed ID: 11148917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Granulocytopoiesis in acute lymphoblastic leukemia in children].
    Vladimirskaia EB; Shershneva NS; Zamaraeva NV; Al Hasan S; Chukanin SN
    Ter Arkh; 1988; 60(5):29-33. PubMed ID: 3175924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
    J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of stromal microenvironment of the bone marrow during remission of acute lymphoblastic leukemia in children].
    Egamberdiev O
    Pediatriia; 1991; (11):50-4. PubMed ID: 1766741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
    Hijiya N; Gajjar A; Zhang Z; Sandlund JT; Ribeiro RC; Rubnitz JE; Jeha S; Liu W; Cheng C; Raimondi SC; Behm FG; Rivera GK; Relling MV; Pui CH
    Leukemia; 2004 Oct; 18(10):1581-6. PubMed ID: 15356657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation.
    Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H
    Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
    AbdElAal Asmaa A; Afify RA; Zaher AE; ElGammal MM; Atef AM
    Hematology; 2015 Oct; 20(9):504-10. PubMed ID: 25885121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.
    Laughton SJ; Ashton LJ; Kwan E; Norris MD; Haber M; Marshall GM
    J Clin Oncol; 2005 Apr; 23(10):2264-71. PubMed ID: 15800317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Tacik J; Skoczeń S; Armata J; Balwierz W
    Przegl Lek; 1992; 49(3):102-3. PubMed ID: 1438896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.